Document is current
Any future updates will be listed below
-
Authors
Hiken, Jeffrey
Earls, Jon
Flanagan, Kevin C.
Wellinghoff, Rachel L.
Ponder, Michelle
Messina, David N.
Glasscock, Jarret I.
Duncavage, Eric J.
-
Funding
Funding for this research was provided by:
Cofactor Genomics, Inc
- License Information
-
More Information
Article History
Received: 29 May 2024
Accepted: 17 December 2024
First Online: 7 January 2025
Declarations
:
: This study was approved by Institutional Review Boards WCG 20201975 (WCG Clinical, Inc., Princeton, New Jersey, IORG0000432), and Advarra Pro00051202 (Advarra, Inc., Columbia, Maryland, IORG0000635). Patients were consented by IRB WCG 20201975 and IRB Advarra Pro00051202. If patients were deceased or lost to follow-up, the need for consent to participate was waived by IRB WCG 20201975 and IRB Advarra Pro00051202.
: Not applicable.
: Authors receive salary and/or hold stock in Cofactor Genomics.
